Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumor × erdafitinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 6 Non-Muscle Invasive Bladder Neoplasms 5 Multiple Myeloma 3 Glioma 3 Carcinoma, Transitional Cell 3 Wilms Tumor 2 Urothelial Cancer 2 Rhabdoid Tumor 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Neoplasms 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Acrocephalosyndactylia 2 Xanthogranuloma, Juvenile 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rare Tumour 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1

Interventions

Injections 22 toripalimab 13 pembrolizumab 13 tislelizumab 11 Gemcitabine 8 Cisplatin 7 Carboplatin 7 atezolizumab 6 spartalizumab 5 Paclitaxel 5 Oxaliplatin 5 Leucovorin 5 Irinotecan 5 Fluorouracil 5 Bevacizumab 5 Nivolumab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 Drug Therapy 3 Docetaxel 3 Cyclophosphamide 3 Cetuximab 3 Albumin-Bound Paclitaxel 3 penpulimab 2 niraparib 2 lenvatinib 2 glumetinib 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04083976 2026-02-04

RAGNAR

Janssen Research & Development, LLC

Phase 2 Active not recruiting

316 enrolled 15 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡